Arcadia Biosciences, Inc.
RKDAUS売上高
$5M
百万USD
営業利益
$-2M
百万USD
純利益
$-2M
百万USD
ROE
-
最新FY
EPS
$-1.71
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $1M | $2M | $0.11 |
| FY2021 | Q2 | $1M | $-5M | - |
| FY2021 | Q3 | $2M | $-2M | - |
| FY2021 | FY | $7M | $-15M | - |
| FY2022 | Q1 | $3M | $-4M | $-0.20 |
| FY2022 | Q2 | $4M | $-4M | $-0.17 |
| FY2022 | Q3 | $2M | $-3M | $-0.12 |
| FY2022 | FY | $10M | $-15M | $-25.65 |
| FY2023 | Q1 | $2M | $-9M | $-10.86 |
| FY2023 | Q2 | $1M | $1M | $0.61 |
| FY2023 | Q3 | $2M | $-3M | $-1.89 |
| FY2023 | FY | $5M | $-14M | - |
| FY2024 | Q1 | $1M | $-2M | $-1.78 |
| FY2024 | Q2 | $1M | $1M | $0.78 |
| FY2024 | Q3 | $2M | $-2M | $-1.18 |
| FY2024 | FY | $5M | $-7M | $-5.17 |
| FY2025 | Q1 | $1M | $3M | $1.90 |
| FY2025 | Q2 | $1M | $-4M | $-3.26 |
| FY2025 | Q3 | $1M | $1M | $0.62 |
| FY2025 | FY | $5M | $-2M | $-1.71 |
| FY2026 | Q1 | $1M | $-4M | $-2.11 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $1M | $1M | $8M | $7M | $10M | $5M | $5M | $5M |
| 営業利益 | $-19M | $-14M | $-17M | $-19M | $-13M | $-36M | $-19M | $-14M | $-4M | $-2M |
| 純利益 | $-20M | $-16M | $-13M | $-29M | $-5M | $-15M | $-15M | $-14M | $-7M | $-2M |
| 総資産 | $57M | $17M | $24M | $33M | $47M | $44M | $29M | $20M | $14M | $7M |
| 純資産 | - | - | - | $8M | $29M | $31M | $21M | $13M | $6M | $4M |
| 自己資本 | $22M | $8M | $13M | $8M | $28M | $31M | $21M | $13M | $6M | - |
| 営業CF | - | - | $-14M | $-17M | $-30M | $-26M | $-14M | $-15M | $-10M | $-5M |
| EPS | - | - | - | - | - | - | $-25.65 | - | $-5.17 | $-1.71 |
| BPS | $0.50 | $3.75 | $2.68 | $0.89 | $1.30 | $1.40 | $24.53 | $9.42 | $4.55 | - |
| ROE | -88.4% | -196.2% | -105.2% | -373.8% | -16.8% | -47.1% | -73.1% | -108.9% | -113.1% | - |